Purple Biotech Book Value Per Share Growth & History (PPBT)
Purple Biotech's book value per share was $0.01 for fiscal 2025.
View full Purple Biotech company overviewPurple Biotech annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.01 | -$0.06 | −91.78% |
| 2024 | 2024-12-31 | $0.06 | -$0.07 | −53.12% |
| 2023 | 2023-12-31 | $0.14 | -$0.12 | −46.60% |
| 2022 | 2022-12-31 | $0.25 | -$0.11 | −30.30% |
| 2021 | 2021-12-31 | $0.36 | -$4.25 | −92.10% |
| 2020 | 2020-12-31 | $4.61 | $4.08 | +766.01% |
| 2019 | 2019-12-31 | $0.53 | -$0.12 | −18.96% |
| 2018 | 2018-12-31 | $0.66 | -$0.13 | −16.09% |
| 2017 | 2017-12-31 | $0.78 | -$1.54 | −66.32% |
| 2016 | 2016-12-31 | $2.33 | $1.84 | +374.78% |
| 2015 | 2015-12-31 | $0.49 | — | — |
Purple Biotech quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.01 | -$0.05 | −88.96% |
| Q1 2026 | 2026-03-31 | $0.01 | — | — |
| Q4 2025 | 2025-12-31 | $0.01 | -$0.06 | −91.78% |
| Q3 2025 | 2025-09-30 | $0.02 | — | — |
| Q2 2025 | 2025-06-30 | $0.06 | — | — |
| Q4 2024 | 2024-12-31 | $0.06 | -$0.07 | −53.12% |
| Q4 2023 | 2023-12-31 | $0.14 | -$0.12 | −46.60% |
| Q4 2022 | 2022-12-31 | $0.25 | -$0.11 | −30.30% |
| Q4 2021 | 2021-12-31 | $0.36 | -$4.25 | −92.10% |
| Q4 2020 | 2020-12-31 | $4.61 | $4.08 | +766.01% |
| Q4 2019 | 2019-12-31 | $0.53 | -$0.12 | −18.96% |
| Q4 2018 | 2018-12-31 | $0.66 | $0.19 | +42.05% |
| Q4 2017 | 2017-12-31 | $0.46 | — | — |
Purple Biotech book value per share trends
Over the last five fiscal years, Purple Biotech's book value per share decreased from $4.61 to $0.01, a change of -$4.61. The latest reported quarter, Q2 2026, shows $0.01.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Purple Biotech source filings ↗